COL5A1 rs12722 polymorphism is not associated with passive muscle stiffness and sports-related muscle injury in Japanese athletes.


Journal

BMC medical genetics
ISSN: 1471-2350
Titre abrégé: BMC Med Genet
Pays: England
ID NLM: 100968552

Informations de publication

Date de publication:
02 12 2019
Historique:
received: 16 06 2019
accepted: 20 11 2019
entrez: 4 12 2019
pubmed: 4 12 2019
medline: 15 2 2020
Statut: epublish

Résumé

Poor joint flexibility has been repeatedly proposed as a risk factor for muscle injury. The C-to-T polymorphism (rs12722) in the 3'-untranslated region of the collagen type V α1 chain gene (COL5A1) is reportedly associated with joint flexibility. Flexibility of a normal joint is largely determined by passive muscle stiffness, which is influenced by intramuscular collagenous connective tissues including type V collagen. The present study aimed to test the hypothesis that the COL5A1 rs12722 polymorphism influences joint flexibility via passive muscle stiffness, and is accordingly associated with the incidence of muscle injury. In Study 1, we examined whether the rs12722 polymorphism is associated with joint flexibility and passive muscle stiffness in 363 healthy young adults. Joint flexibility was evaluated by passive straight-leg-raise and sit-and-reach tests, and passive muscle stiffness was measured using ultrasound shear wave elastography. In Study 2, the association of the rs12722 polymorphism with sports-related muscle injury was assessed in 1559 Japanese athletes. Muscle injury history and severity were assessed by a questionnaire. In both Study 1 and Study 2, the rs12722 C-to-T polymorphism in the COL5A1 was determined using the TaqMan SNP Genotyping Assay. Study 1 revealed that the rs12722 polymorphism had no significant effect on range of motion in passive straight-leg-raise and sit-and-reach tests. Furthermore, there was no significant difference in passive muscle stiffness of the hamstring among the rs12722 genotypes. In Study 2, rs12722 genotype frequencies did not differ between the muscle injury and no muscle injury groups. Moreover, no association was observed between rs12722 polymorphism and severity of muscle injury. The present study does not support the view that COL5A1 rs12722 polymorphism has a role as a risk factor for sports-related muscle injury, or that it is a determinant for passive muscle stiffness in a Japanese population.

Sections du résumé

BACKGROUND
Poor joint flexibility has been repeatedly proposed as a risk factor for muscle injury. The C-to-T polymorphism (rs12722) in the 3'-untranslated region of the collagen type V α1 chain gene (COL5A1) is reportedly associated with joint flexibility. Flexibility of a normal joint is largely determined by passive muscle stiffness, which is influenced by intramuscular collagenous connective tissues including type V collagen. The present study aimed to test the hypothesis that the COL5A1 rs12722 polymorphism influences joint flexibility via passive muscle stiffness, and is accordingly associated with the incidence of muscle injury.
METHODS
In Study 1, we examined whether the rs12722 polymorphism is associated with joint flexibility and passive muscle stiffness in 363 healthy young adults. Joint flexibility was evaluated by passive straight-leg-raise and sit-and-reach tests, and passive muscle stiffness was measured using ultrasound shear wave elastography. In Study 2, the association of the rs12722 polymorphism with sports-related muscle injury was assessed in 1559 Japanese athletes. Muscle injury history and severity were assessed by a questionnaire. In both Study 1 and Study 2, the rs12722 C-to-T polymorphism in the COL5A1 was determined using the TaqMan SNP Genotyping Assay.
RESULTS
Study 1 revealed that the rs12722 polymorphism had no significant effect on range of motion in passive straight-leg-raise and sit-and-reach tests. Furthermore, there was no significant difference in passive muscle stiffness of the hamstring among the rs12722 genotypes. In Study 2, rs12722 genotype frequencies did not differ between the muscle injury and no muscle injury groups. Moreover, no association was observed between rs12722 polymorphism and severity of muscle injury.
CONCLUSIONS
The present study does not support the view that COL5A1 rs12722 polymorphism has a role as a risk factor for sports-related muscle injury, or that it is a determinant for passive muscle stiffness in a Japanese population.

Identifiants

pubmed: 31791263
doi: 10.1186/s12881-019-0928-2
pii: 10.1186/s12881-019-0928-2
pmc: PMC6889657
doi:

Substances chimiques

COL5A1 protein, human 0
Collagen Type V 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

192

Références

BMC Med Genet. 2018 Dec 20;19(1):217
pubmed: 30572822
Biophys J. 1995 Mar;68(3):1027-44
pubmed: 7756523
BMC Musculoskelet Disord. 2013 Jul 26;14:221
pubmed: 23890452
J Exerc Nutrition Biochem. 2014 Jun;18(2):205-14
pubmed: 25566457
J Strength Cond Res. 2011 Dec;25(12):3391-8
pubmed: 21969080
Am J Sports Med. 2003 Jan-Feb;31(1):41-6
pubmed: 12531755
Ann Hum Genet. 2013 May;77(3):204-14
pubmed: 23347277
Behav Genet. 2016 Mar;46(2):217-27
pubmed: 26481792
Am J Sports Med. 2009 Nov;37(11):2234-40
pubmed: 19654427
Br J Sports Med. 2006 Mar;40(3):193-201
pubmed: 16505073
Scand J Med Sci Sports. 2006 Feb;16(1):19-26
pubmed: 16430677
Sci Data. 2017 Aug 29;4:170105
pubmed: 28850115
Phys Ther. 2010 Mar;90(3):438-49
pubmed: 20075147
J Muscle Res Cell Motil. 2003;24(2-3):175-89
pubmed: 14609029
J Exerc Nutrition Biochem. 2015 Jun;19(2):49-53
pubmed: 26244122
Biochem J. 1984 May 1;219(3):1017-26
pubmed: 6743238
Scand J Med Sci Sports. 2017 Jan;27(1):99-106
pubmed: 26669626
Scand J Med Sci Sports. 2011 Dec;21(6):e266-72
pubmed: 21362053
Scand J Med Sci Sports. 2009 Dec;19(6):803-10
pubmed: 19422640
Br J Sports Med. 2009 May;43(5):352-6
pubmed: 19193663
Br J Sports Med. 2016 Jun;50(12):731-7
pubmed: 26746908
Exerc Sport Sci Rev. 2011 Oct;39(4):191-8
pubmed: 21697718
Med Sci Sports Exerc. 2019 Jan;51(1):19-26
pubmed: 30113520
Oncotarget. 2017 Dec 27;9(20):15365-15374
pubmed: 29632650
Matrix Biol. 2011 Jun;30(5-6):338-45
pubmed: 21609763
Int J Sports Med. 2018 Feb;39(2):110-114
pubmed: 29190853
Scand J Med Sci Sports. 1997 Aug;7(4):195-202
pubmed: 9241023
Physiol Genomics. 2016 Mar;48(3):183-90
pubmed: 26715623
J Sports Med Phys Fitness. 2015 Nov;55(11):1348-53
pubmed: 25583227
Br J Sports Med. 2009 May;43(5):357-65
pubmed: 18443036
Eur J Appl Physiol. 2012 Jul;112(7):2749-55
pubmed: 22124523
Clin Biomech (Bristol, Avon). 2001 Feb;16(2):87-101
pubmed: 11222927
Med Sci Sports Exerc. 2018 Feb;50(2):361-368
pubmed: 28976491

Auteurs

Eri Miyamoto-Mikami (E)

Institute of Health and Sports Science & Medicine, Juntendo University, 1-1 Hiraka-gakuendai, Inzai City, Chiba, 270-1695, Japan. miyamoto.mikami@gmail.com.
Juntendo Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan. miyamoto.mikami@gmail.com.

Naokazu Miyamoto (N)

Graduate School of Health and Sports Science, Juntendo University, Chiba, Japan.

Hiroshi Kumagai (H)

Institute of Health and Sports Science & Medicine, Juntendo University, 1-1 Hiraka-gakuendai, Inzai City, Chiba, 270-1695, Japan.
Research Fellow of Japanese Society for the Promotion of Science, Tokyo, Japan.

Kosuke Hirata (K)

Research Fellow of Japanese Society for the Promotion of Science, Tokyo, Japan.
Graduate School of Engineering and Science, Shibaura Institute of Technology, Saitama, Japan.

Naoki Kikuchi (N)

Department of Training Science, Nippon Sport Science University, Tokyo, Japan.

Hirofumi Zempo (H)

Institute of Health and Sports Science & Medicine, Juntendo University, 1-1 Hiraka-gakuendai, Inzai City, Chiba, 270-1695, Japan.
Faculty of Health and Nutrition, Tokyo Seiei College, Tokyo, Japan.

Noriko Kimura (N)

Graduate School of Sport and Exercise Sciences, Osaka University of Health and Sport Sciences, Osaka, Japan.

Nobuhiro Kamiya (N)

Faculty of Budo and Sport Studies, Tenri University, Nara, Japan.

Hiroaki Kanehisa (H)

Faculty of Sport and Health Science, Ritsumeikan University, Shiga, Japan.

Hisashi Naito (H)

Institute of Health and Sports Science & Medicine, Juntendo University, 1-1 Hiraka-gakuendai, Inzai City, Chiba, 270-1695, Japan.
Juntendo Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan.
Graduate School of Health and Sports Science, Juntendo University, Chiba, Japan.

Noriyuki Fuku (N)

Institute of Health and Sports Science & Medicine, Juntendo University, 1-1 Hiraka-gakuendai, Inzai City, Chiba, 270-1695, Japan.
Juntendo Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan.
Graduate School of Health and Sports Science, Juntendo University, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH